Abstract is: Helen Rees OBE GCOB is a medical researcher and the founder and Executive Director of the Wits Reproductive Health and HIV Institute (Wits RHI) of the University of Witwatersrand. She has led many HIV prevention and sexual and reproductive health studies and advised on vaccination strategies to help prevent various medical conditions.
| human | Q5 |
| P2671 | Google Knowledge Graph ID | /g/11dxb216f0 |
| P1960 | Google Scholar author ID | Zoi9JkkAAAAJ |
| P496 | ORCID iD | 0000-0003-1442-6734 |
| P2038 | ResearchGate profile ID | Helen_Rees2 |
| P1153 | Scopus author ID | 57203557180 |
| P214 | VIAF ID | 306342322 |
| P166 | award received | Harry Oppenheimer Fellowship Award | Q5671387 |
| Member of the Academy of Science of South Africa | Q75746002 | ||
| Officer of the Order of the British Empire | Q10762848 | ||
| P69 | educated at | Harvard Business School | Q49126 |
| Murray Edwards College | Q1195404 | ||
| P108 | employer | University of the Witwatersrand | Q534643 |
| P734 | family name | Rees | Q21449596 |
| Rees | Q21449596 | ||
| Rees | Q21449596 | ||
| P735 | given name | Helen | Q13376892 |
| Helen | Q13376892 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q40466927 | "Bitten By Shyness": Menstrual Hygiene Management, Sanitation, and the Quest for Privacy in South Africa. |
| Q89127480 | "It Was Not My Aim to Sleep There": The Impact of Timing and Location of Sex on Adherence to Coitally-Dependent HIV Pre-exposure Prophylaxis |
| Q46170545 | "You must do the test to know your status": attitudes to HIV voluntary counseling and testing for adolescents among South African youth and parents |
| Q46877322 | A case study of antenatal syphilis screening in South Africa: successes and challenges |
| Q37863864 | A community-based study to examine the effect of a youth HIV prevention intervention on young people aged 15-24 in South Africa: results of the baseline survey |
| Q37503505 | A prospective study of the effect of pregnancy on CD4 counts and plasma HIV-1 RNA concentrations of antiretroviral-naive HIV-1-infected women |
| Q35176007 | A tale of two countries: rethinking sexual risk for HIV among young people in South Africa and the United States |
| Q36487827 | Acyclovir Prophylaxis Reduces the Incidence of Herpes Zoster Among HIV-Infected Individuals: Results of a Randomized Clinical Trial |
| Q30363571 | Addressing the Achilles' heel in the HIV care continuum for the success of a test-and-treat strategy to achieve an AIDS-free generation. |
| Q49525382 | Advancing STI priorities in the SDG era: priorities for action |
| Q97677689 | Age-specific risk scores do not improve HIV-1 prediction among women in South Africa |
| Q85092467 | Antiretrovirals for safer conception for HIV-negative women and their HIV-1-infected male partners: how safe and how available? |
| Q39559497 | Are targeted HIV prevention activities cost-effective in high prevalence settings? Results from a sexually transmitted infection treatment project for sex workers in Johannesburg, South Africa |
| Q49069038 | At the Heart of the Problem: Health in Johannesburg's Inner-City |
| Q35184921 | Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study |
| Q37285630 | Bone mineral density in young women aged 19-24 after 4-5 years of exclusive and mixed use of hormonal contraception |
| Q94946359 | COVID-19 in Africa: care and protection for frontline healthcare workers |
| Q46352635 | Challenge of evaluating a national HIV prevention programme: the case of loveLife, South Africa |
| Q33436735 | Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study |
| Q58595655 | Collateral benefits: how the practical application of Good Participatory Practice can strengthen HIV research in sub-Saharan Africa |
| Q93162011 | Comparisons of Human Immunodeficiency Virus Type 1 Envelope Variants in Blood and Genital Fluids near the Time of Male-to-Female Transmission |
| Q50142380 | Concordance of self-reported hormonal contraceptive use and presence of exogenous hormones in serum among African women |
| Q37148860 | Concurrent sexual partnerships and human immunodeficiency virus risk among South African youth |
| Q47955380 | Consistent condom use in South African youth's most recent sexual relationships |
| Q36490642 | Continued high risk sexual behavior following diagnosis with acute HIV infection in South Africa and Malawi: implications for prevention |
| Q33304052 | Contraception use and pregnancy among 15-24 year old South African women: a nationally representative cross-sectional survey |
| Q40793668 | Contraceptive implants and efavirenz-based ART: friend or foe? |
| Q37598620 | Contraceptive method and pregnancy incidence among women in HIV-1-serodiscordant partnerships |
| Q38105957 | Controlling the HIV epidemic with antiretrovirals: IAPAC consensus statement on treatment as prevention and preexposure prophylaxis |
| Q37505057 | Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices |
| Q34436552 | DMPA and HIV: why we need a trial |
| Q33881449 | Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial |
| Q44668376 | Detection of raised FSH levels among older women using depomedroxyprogesterone acetate and norethisterone enanthate |
| Q39671663 | Dual protection in sexually active women. |
| Q89608801 | ECHO: context and limitations - Authors' reply |
| Q59153632 | Early Coital Debut and Associated HIV Risk Factors Among Young Women and Men in South Africa |
| Q46598837 | Early coital debut and associated HIV risk factors among young women and men in South Africa |
| Q36063532 | Efavirenz conceptions and regimen management in a prospective cohort of women on antiretroviral therapy |
| Q36497840 | Effect of Condom Use on Per-act HSV-2 Transmission Risk in HIV-1, HSV-2-discordant Couples |
| Q37871041 | Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial |
| Q36566659 | Effectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy |
| Q94567658 | Effects of depot medroxyprogesterone acetate, copper intrauterine devices, and levonorgestrel implants on early HIV disease progression |
| Q42662641 | Enhancing global control of alcohol to reduce unsafe sex and HIV in sub-Saharan Africa |
| Q57976096 | Estimating the Population Size of Female Sex Workers in Three South African Cities: Results and Recommendations From the 2013-2014 South Africa Health Monitoring Survey and Stakeholder Consensus |
| Q33697958 | Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk |
| Q36775468 | Ethical considerations for vaccination programmes in acute humanitarian emergencies |
| Q33643649 | Factors associated with self-efficacy for condom use and sexual negotiation among South african youth |
| Q40684357 | Field evaluation of Standard Diagnostics' Bioline HIV/Syphilis Duo test among female sex workers in Johannesburg, South Africa |
| Q37331590 | Geographic distribution of human immunodeficiency virus in South Africa. |
| Q36119002 | Growing inequities in maternal health in South Africa: a comparison of serial national household surveys |
| Q64882362 | Guidelines to support HIV-affected individuals and couples to achieve pregnancy safely: Update 2018. |
| Q45184870 | HIV and sexual behavior among young people: the South African paradox |
| Q47098854 | HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project. |
| Q42248259 | HIV prevalence and risk in long-distance truck drivers in South Africa: a national cross-sectional survey |
| Q57176333 | HIV retesting in pregnant women in South Africa: Outcomes of a quality improvement project targeting health systems' weaknesses |
| Q38194254 | HPV vaccines to prevent cervical cancer and genital warts: an update |
| Q46253583 | Heterosexual anal intercourse increases risk of HIV infection among young South African men. |
| Q39212171 | Hidden harms: women's narratives of intimate partner violence in a microbicide trial, South Africa |
| Q58449595 | High HIV incidence or poor test performance? |
| Q34257078 | High incidence of unplanned pregnancy after antiretroviral therapy initiation: findings from a prospective cohort study in South Africa |
| Q39741284 | High pregnancy intentions and missed opportunities for patient-provider communication about fertility in a South African cohort of HIV-positive women on antiretroviral therapy |
| Q45274314 | Highly efficient HIV transmission to young women in South Africa |
| Q21144588 | Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis |
| Q37088950 | Hormonal contraceptive use and risk of HIV-1 disease progression |
| Q35080217 | How much demand for New HIV prevention technologies can we really expect? Results from a discrete choice experiment in South Africa |
| Q56518363 | Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign |
| Q80399956 | Identifying acute HIV infection--a major new public health challenge |
| Q34168214 | Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa |
| Q57103589 | Impacts of Climate Change on Health and Wellbeing in South Africa |
| Q90142233 | Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards? |
| Q36235776 | Increased Access to Antiretroviral Therapy Is Associated with Reduced Maternal Mortality in Johannesburg, South Africa: An Audit from 2003-2012 |
| Q35214337 | Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples |
| Q30823365 | Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial |
| Q39140442 | Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort |
| Q57286625 | Integrating Cervical Cancer Screening Into Safer Conception Services to Improve Women's Health Outcomes: A Pilot Study at a Primary Care Clinic in South Africa. |
| Q30392664 | Intersection of HIV and Reproductive Health |
| Q35062487 | Investing in the future: lessons learnt from communicating the results of HSV/ HIV intervention trials in South Africa |
| Q37324101 | Keep them in school: the importance of education as a protective factor against HIV infection among young South African women |
| Q37031127 | Local and foreign authorship of maternal health interventional research in low- and middle-income countries: systematic mapping of publications 2000-2012. |
| Q40014913 | Low Receipt and Uptake of Safer Conception Messages in Routine HIV Care: Findings From a Prospective Cohort of Women Living With HIV in South Africa |
| Q51635633 | Managing men: women's dilemmas about overt and covert use of barrier methods for HIV prevention. |
| Q30381894 | Mapping of research on maternal health interventions in low- and middle-income countries: a review of 2292 publications between 2000 and 2012 |
| Q64983267 | Model-estimated effectiveness of single dose 9-valent HPV vaccination for HIV-positive and HIV-negative females in South Africa. |
| Q34081339 | Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study |
| Q57986041 | Orphanhood and Completion of Compulsory School Education Among Young People in South Africa: Findings From a National Representative Survey |
| Q34138687 | PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial |
| Q38575199 | Path to impact: A report from the Bill and Melinda Gates Foundation convening on maternal immunization in resource-limited settings; Berlin - January 29-30, 2015. |
| Q37209508 | Perspectives on the methods of a large systematic mapping of maternal health interventions |
| Q38635268 | Planning for HIV preexposure prophylaxis introduction: lessons learned from contraception |
| Q30399268 | Pre-exposure rabies prophylaxis: a systematic review |
| Q55044019 | Predictors of condom use among young adults in South Africa: the Reproductive Health and HIV Research Unit National Youth Survey. |
| Q51025566 | Predictors of dual method use for pregnancy and HIV prevention among adolescent South African women. |
| Q58119532 | Pregnancy and infant outcomes among women using the dapivirine vaginal ring in early pregnancy |
| Q33827872 | Prevalence of morbidity associated with abortion before and after legalisation in South Africa |
| Q46825799 | Prevalence of parental death among young people in South Africa and risk for HIV infection |
| Q56954236 | Rationale and design of a multi-center, open-label, randomised clinical trial comparing HIV incidence and contraceptive benefits in women using three commonly-used contraceptive methods (the ECHO study) |
| Q57980411 | Rationale and design of a multi-center, open-label, randomised clinical trial comparing HIV incidence and contraceptive benefits in women using three commonly-used contraceptive methods (the ECHO study) |
| Q59153643 | Response to letters from Jewkes, Parker and Colvin, and Potterat et al |
| Q33944686 | Safety and efficacy of initiating highly active antiretroviral therapy in an integrated antenatal and HIV clinic in Johannesburg, South Africa |
| Q55119981 | Safety of a silicone elastomer vaginal ring as potential microbicide delivery method in African women: A Phase 1 randomized trial. |
| Q43809456 | Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women |
| Q40083232 | Sexual and reproductive health outcomes among female sex workers in Johannesburg and Pretoria, South Africa: Recommendations for public health programmes |
| Q35895962 | Sexual power and HIV risk, South Africa |
| Q55051749 | Sexual violence and reproductive health outcomes among South African female youths: a contextual analysis. |
| Q102151799 | Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant |
| Q34037516 | Short-course antiretroviral therapy in primary HIV infection |
| Q92486162 | Targeting and vaccine durability are key for population-level impact and cost-effectiveness of a pox-protein HIV vaccine regimen in South Africa |
| Q90210146 | Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial |
| Q59153626 | The Authors reply |
| Q39674031 | The Cape Town Declaration on Vaccines 2012: Unlocking the full potential of vaccines in Africa |
| Q40213344 | The MET receptor tyrosine kinase contributes to invasive tumour growth in rhabdomyosarcomas |
| Q37836637 | The global roadmap for advancing development of vaccines against sexually transmitted infections: Update and next steps. |
| Q34394668 | The impact of age on the epidemiology of incomplete abortions in South Africa after legislative change |
| Q39559500 | The importance of context: model projections on how microbicide impact could be affected by the underlying epidemiologic and behavioral situation in 2 African settings |
| Q43857892 | The medical proof doesn't get much better than VMMC. |
| Q38849713 | The science of Durban, AIDS 2016 |
| Q30361444 | Transformation of HIV from pandemic to low-endemic levels: a public health approach to combination prevention. |
| Q37312664 | Treatment And Prevention for female Sex workers in South Africa: protocol for the TAPS Demonstration Project |
| Q35699938 | Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study |
| Q33988276 | Use of injectable progestin contraception and risk of STI among South African women |
| Q34732730 | Using HPV vaccination for promotion of an adolescent package of care: opportunity and perspectives |
| Q57976097 | Using IBBS Survey Data and Stakeholder Consensus to Estimate Population Size of Female Sex Workers in Three South African Cities: Results and Recommendations From the 2013-14 South Africa Health Monitoring Survey (Preprint) |
| Q38638346 | Using surrogate vaccines to assess feasibility and acceptability of future HIV vaccine trials in men: a randomised trial in inner-city Johannesburg, South Africa |
| Q42230455 | Vaccines against sexually transmitted infections: the way forward |
| Q57460911 | Virological remission after antiretroviral therapy interruption in female African HIV seroconverters |
| Q34888811 | Vulnerability of women in southern Africa to infection with HIV: biological determinants and priority health sector interventions |
| Q42376936 | When are declines in condom use while using PrEP a concern? Modelling insights from a Hillbrow, South Africa case study |
| Q59153647 | Young peopleʼs sexual health in South Africa: HIV prevalence and sexual behaviors from a nationally representative household survey |
| Category:Helen Rees | wikimedia | |
| Helen Rees | wikipedia |
Search more.